Policy Recommendations for Strengthening the Accelerated Approval Program for Oncology Drugs
Memo: Delivered to the U.S. Food and Drug Administration (FDA)
Policy
Studies from Penn LDI on Medicare Post-Acute Care
Comment: Submitted to the U.S. Committee on Ways & Means Subcommittee on Health
Print:
In March 2025, University of Pennsylvania Leonard Davis Institute of Health Economics (LDI) Executive Director Rachel M. Werner, MD, PhD submitted research and recommendations to the U.S. Committee on Ways & Means Subcommittee on Health in response to a hearing held by the subcommittee entitled After the Hospital: Ensuring Access to Quality Post-acute Care. Dr. Werner’s comment featured key takeaways from studies conducted by herself and other LDI Fellows and included three policy recommendations to improve post-acute care.
Views expressed by the researchers are their own and do not necessarily represent those of the University of Pennsylvania Health System (Penn Medicine) or the University of Pennsylvania.
More on Policy at LDI
Estimated Overdose Deaths Due to the One Big Beautiful Bill Act
Letter: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Health Impacts of SNAP Provisions in the One Big Beautiful Bill Act
Letter: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Impact of House Budget Reconciliation Bill on Insurance Coverage
Comment: Delivered to the Senate Committee on Health, Education, Labor, and Pensions
Projected Mortality Impacts of the Budget Reconciliation Bill
Letter: Response to Request for Technical Assistance
Loss of Subsidized Drug Coverage and Mortality Following Medicaid Disenrollment: Translating our Findings and Implications for Medicaid Policy
Memo: Supplement to Response to Request for Technical Assistance